Drug
Who makes acamprosate calcium enteric-coated?
2 companies list acamprosate calcium enteric-coated as a human prescription drug. Forms: tablet, delayed release. Routes: oral.
Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology
Companies listing acamprosate calcium enteric-coated
| Company | Forms | Application | NDCs | Registered sites |
|---|---|---|---|---|
| NCS HealthCare of KY, LLC dba Vangard LabsUnited States | tablet, delayed release | ANDAANDA200142 | 1 | 1 |
| Mylan Pharmaceuticals, Inc. | tablet, delayed release | ANDAANDA200142 | 1 | 0 |
Enquiry
Common questions
- Who makes acamprosate calcium enteric-coated?
- 2 companies list acamprosate calcium enteric-coated as a human prescription drug in the openFDA NDC Directory, led by NCS HealthCare of KY, LLC dba Vangard Labs, Mylan Pharmaceuticals, Inc.. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
- Is there a generic acamprosate calcium enteric-coated?
- 2 companies list acamprosate calcium enteric-coated under an abbreviated new drug application (ANDA), the application type used for generics. Listing status is from the NDC Directory; it is not a statement of availability.